Some Central New Yorkers with and without diabetes participated in a study of a pain-free glucose sensor that’s in development, called Biologue. The device, the size of a round pill box, would eliminate the repeated finger sticks that are required to test blood sugars multiple times a day in people with type 1 or type 2 diabetes.
Biologue is an electrochemical biosensor that measures glucose within the interstitial fluid just below the surface of the skin. It transmits that data wirelessly to a hand-held monitor. It has not yet been approved by the Food and Drug Administration, but initial results are encouraging, says Ruth Weinstock MD, PhD, medical director of the Joslin Diabetes Center at Upstate and the lead investigator for the study, paid for in part by the National Institutes of Health.
The company that makes Biologue, Ultradian Diagnostics in Rensselaer, wants to make it smaller and flexible, like a Band-Aid, which could be worn for days without recalibration. To do that, the company is collaborating with the Smart System Technology and Commercialization Center in Canandaigua, a microsystems lab that specializes in micro electromechanical systems, or MEMS. Upstate conducted the first testing of this device in humans.
Weinstock was impressed with the accuracy of the sensor, compared with continuous glucose monitoring devices already on the market. “We believe this new technology could greatly benefit patients with diabetes and move us forward in the development of the artificial pancreas.”
The pancreas is the organ that produces the hormone insulin, which helps the body manage blood sugar.